No spam - just the good stuff

Subscribe to our newsletter

News

Diagnostic Tools

Cancer blood test maker Grail files for Nasdaq IPO

Diagnostic Tools

Building an artificial immune system

Diagnostic Tools

Longevity boost as nanotech reveals inner cell workings

A ground-breaking discovery is taking researchers deep into the heart of cells allowing them to measure even the tiniest movements.

Diagnostic Tools

Precious nano metals hold key to new treatments

Diagnostic Tools

Nanotechnology – Longevity’s small revolution

Diagnostic Tools

New technique spots thrombosis in a single drop of blood

Diagnostic Tools

Revolutionary nanomaterial heals damage after heart attack giving life extension hope

Diagnostic Tools

Contact lens set to revolutionise medical diagnoses – and lifespan

Diagnostic Tools

Blood-brain barrier (BBB) replicated on a chip

Diagnostic Tools

Magnetic nano-probe explores the inside of human cells

Diagnostic Tools

NanoFlares detect cancer biomarkers

Diagnostic Tools

Harvard graduate designs AI for TB resistance – and people will live longer as a result

Diagnostic Tools

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.